L20: Vaccines Flashcards

1
Q

Passive immunity

A

when the antibodies produced by one organism are transferred to and protect another.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sources of passive immunity

A

1) mothers antibodies across placenta
2) maternal antibodies in colostrum/breast milk
3) serum from other organism introduced into body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clinical scenarios where antibody therapy (passive immunity) is useful

A

a. Patient is immunodeficient or otherwise vulnerable (has leukemia and gets exposed)
b. Patient is exposed and could experience complications before traditional treatments are effective (tetanus exposure in someone with up-to-date vaccine, anthrax infection to remove the toxin).
c. Individual bitten by venomous snake or insect – horse antibodies tie it up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Problems with passive immune therapy

A

a. Short term and no memory developed to pathogen, toxin or venom.
b. Serum sickness – may develop antibodies to the foreign antibodies: type III hypersensitivity.
c. Engineered monoclonal “humanized” antibodies make this less of a problem.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What’s considered Active immunity?

A

Vaccines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Who is responsible for the anti-vacc movement and what did he do?

A

In 1998, Andrew Wakefield reported a correlation between symptoms and autism in 12 children and proposed a correlation improved vaccination the rise of autism diagnoses in California, suggesting that thiomersal, a mercury-based preservative,
was the cause.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Methods for making live attenuated vaccines

A

a. Select for growth in culture medium, e.g. Mycobacterium bovis grown on medium with increasing amounts of bile for TB vaccine.
b. Grow virus on another species and they become better at infecting that one than they are at infecting us: Sabine in monkey kidney epithelial cells, rubella on duck embryo cells.
c. Select for growth under non-physiological conditions. FluMist selected at cold temperatures, and can only infect the cooler parts of the upper respiratory tract.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

advantages of live attenuated vaccines

A

a. Mount a full immune response, including class switching and memory cell production and activation of TC cells.
b. Need for fewer (or no) boosters – Sabin oral vaccine requires three exposures because it has three different viruses, and each time only one mounts enough of an infection to produce immunity, but once you’ve got it, you’ve got it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Disadvantages of live attenuated vaccines

A

a. They may revert to virulent form which then gets passed on.
b. They may produce a serious infection in an immune compromised recipient, even when fully attenuated.
c. They may be contaminated with other viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

“Killed” Vaccines

A

from dead bacteria or completely inactivated viruses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Advantages of killed vaccines

A

Once they’re dead, they’re dead. They’re not going to infect the immune compromised. - Salk polio and current pertussis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Disadvantages of killed vaccines

A

a. Must be careful not to denature the proteins needed to provide B cells with epitopes.
b. mainly humoral response
c. need repeated boosters
d. some viruses may get through “alive”
e. can still get bad reactions to multiple agents in whole bacteria (pertussis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Examples of killed vaccines

A

a. injectable flu (both seasonal and H1N1)
b. hepatitis A
c. cholera

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vaccines from Specific Macromolecules

A
purifying macromolecules is a way to get
around the problems of injecting uncharacterized mixtures of molecules into people
    -bacterial lipids and LPS
    -bacterial toxoids
    -pathogen proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

vaccines from bacterial lipids and LPS

A

remember that strep is virulent because its
capsule presents neutrophils from killing it before the body can tag it with antibodies. Well, you can vaccinate with just the capsule.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

vaccines from bacterial toxoids

A

A toxoid is a toxin that has been inactivated enough to be safe, yet will still promote and immune response that will knock out the real toxin used for diphtheria and tetanus toxins, but you have to be careful to inactivate without denaturing.

17
Q

vaccines from pathogen proteins

A

Engineer bacteria, yeast or mammalian tissue culture cells
with the gene for a pathogenic protein. You can then harvest the protein in quantity and inject it as a vaccine. Such vaccines require adjuvants, as the proteins by itself (unlike bacterial lipids and polysaccharides) will not provide a danger signal.

18
Q

Adjuvants

A

a substance that enhances the body’s immune response to an antigen.

19
Q

conjugate vaccines

A

is created by covalently attaching a poor (polysaccharide) antigen to a carrier protein (preferably from the same microorganism), thereby conferring the immunological attributes of the carrier to the attached antigen.

20
Q

example of conjugate vaccine

A

Hib vaccine to Haemophilus influenzai has polysaccharideconjugated to tetanus toxoid.

21
Q

SMAA (solid matrix antibody antigen complex)

A

You can hook both T- and B-cell epitopes to antibodies held on a solid matrix.

22
Q

ISCOM (Immunostimulating complex)

A

activates a TC cell (and possibly TH during cross presentation) – placing the antigens at the center of a detergent complexed with Quil A, a glycoside that can interact with membrane components. This will actually feed the antigen directly into the cell where they can be hydrolyzed in a proteasome and fed into the MHC I complex

23
Q

DNA vaccines

A

is a technique for protecting an animal against disease by injecting it with genetically engineered DNA so cells directly produce an antigen, resulting in a protective immunological response.

24
Q

Method of DNA vaccines

A

a. Grow up a batch of plasmid DNA coding for pathogenic antigens.
b. Inject the DNA into the muscle of the recipient.
c. The DNA is taken up and expressed by the muscles, producing a batch of foreign antigen.
d. The DNA may also be taken up by local dendritic cells, which may in fact do the actual stimulating.
e. The antigens stimulate both humoral and cell-mediated immunity, activating both T and B memory cells.

25
Q

Advantages of DNA vaccines

A

a. need not refrigerate
b. can engineer the same plasmid against more than one pathogen
c. can deliver on particle with gene gun ( no messy needles)
d. can engineer the gene with unmethylated CpG sequences, which will serve as adjuvants, activating TLR9

26
Q

Disadvantages of DNA vaccines

A

a. only works for protein antigens
b. Must be i.m.- can’t use with oral or nasal spray versions.
c. Early version didn’t work very well in humans (great for mice and chickens)

27
Q

Recombinant vector vaccines

A

This is a way of using existing vaccines to confer

immunity on a new and/or especially virulent pathogen.